Sectors
FLNA
Filana Therapeutics, Inc.
0.97
5 x 0.97
11 x 0.99
bid
ask
-
0.04
3.50%
12:26 PM
timesize
| Ytd | -53.36% | |
| 1y | -53.36% |
0.97
day range
1.02
1.00
52 week range
4.98
| Open | 1.02 | Prev Close | 1.01 | Low | 0.97 | High | 1.02 | Mkt Cap | 48.79M |
| Vol | 267.16K | Avg Vol | 381.73K | EPS | -0.47 | P/E | -2.15 | Forward P/E | N/A |
| Beta | -0.73 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 1.25 | 200-d Avg | 2.16 | 1yr Est | 0.00 |
FLNA News
globenewswire.com
Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
AUSTIN, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana The
globenewswire.com
Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII
AUSTIN, Texas, May 05, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana The
defenseworld.net
Zevra Therapeutics (NASDAQ:ZVRA) versus Cassava Sciences (NASDAQ:FLNA) Head-To-Head Contrast
Zevra Therapeutics (NASDAQ: ZVRA - Get Free Report) and Cassava Sciences (NASDAQ: FLNA - Get Free Re